Trump to link autism to Tylenol use during pregnancy The mention of a connection would revive a medical controversy over the use of acetaminophen early in a pregnancy. Axios · Sep 22, 2025
Could This New Drug Be The Safer Way To Fight Obesity? On Friday, Skye Bioscience, Inc. (NASDAQ:SKYE) announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the European Association for the Study of Diabetes (EASD) Annual Meeting. Benzinga · Sep 19, 2025
Five o’clock dinner crowd: why are young Americans eating so early? Gen Z and millennials’ dinner reservations are reportedly inching earlier as they take advantage of happy hour deals The Guardian - US · Sep 19, 2025
Daily arthritis pill could slow progression of diabetes, trial finds The drug is already used to treat several autoimmune diseases, including rheumatoid arthritis, ulcerative colitis, and alopecia The Independent UK · Sep 18, 2025
Novo Nordisk Poised For UNH-Style Comeback: New Data & AI Boost Signal Reversal Novo Nordisk A/S (NYSE:NVO) looks ready to shake off its slump. With weight-loss pills showing blockbuster results, Ozempic proving heart-healthy benefits, and analysts flipping bullish, the stock is starting to resemble UnitedHealth Group Inc.'s (NYSE:UNH) rebound playbook. Benzinga · Sep 18, 2025
Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga · Sep 18, 2025
‘Pioneering’ new weight-loss jab could help keep weight off even after you stop taking it The downfall of drugs such as Mounjaro, Ozempic and Wegovy is many patients regain weight shortly after stopping The Independent UK · Sep 17, 2025
Could This Eli Lilly Oral Pill Be Key To Significant Weight Loss? Eli Lilly and Co (NYSE:LLY) on Tuesday shared detailed results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of oral orforglipron in adults with obesity, or overweight with a weight-related medical problem, and without diabetes. Benzinga · Sep 17, 2025
Vital breakthrough as once-a-day pill can help people lose ‘significant’ weight A fifth of people taking the weight-loss tablet Orforglipron lost 20 per cent of their body weight The Independent UK · Sep 16, 2025
Study recommends ‘planetary diet’ to cut diabetes risk and emissions Researchers say dietary changes are crucial part of effort to tackle global heating The Independent UK · Sep 16, 2025
Weight-loss drugs help stop intrusive thoughts about food, study finds Wegovy also was found to improve mental health, self-confidence and the development of healthier habits The Independent UK · Sep 16, 2025
Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment Novo Nordisk A/S (NYSE:NVO) reportedly said on Tuesday that it intends to seek US regulatory approval for a high-dose version of its weight-loss injection Wegovy (semaglutide), another effort to counter Eli Lilly and Co. (NYSE:LLY). Benzinga · Sep 16, 2025
Weight loss jabs could be effective on children as young as six, study suggests The report did warn that stomach problems are more common among youngsters taking the drugs. Evening Standard · Sep 15, 2025
Obese children as young as six could benefit from weight-loss jabs About a third of children leaving primary school are overweight or living with obesity in England The Independent UK · Sep 15, 2025
Radio France Internationale · Sep 10, 2025 More of the world's children are obese than underweight, UN warns For the first time, more school-aged children are obese than underweight around the world, with the exception of sub-Saharan Africa and South Asia. The warning came in a report released on Wednesday by the United Nations children’s agency Unicef.
The Guardian - UK · Sep 10, 2025 Why have energy drinks been banned for under-16s in England? The real question is why it wasn’t done sooner Expecting parents to police kids’ intake of a psychoactive drug is unrealistic and unfair given the power of social media, says Prof Devi Sridhar, chair of global public health at the University of Edinburgh
The Independent UK · Sep 10, 2025 More children now obese than underweight for first time ever Major study by Unicef finds 391 million children across the globe now overweight or obese
The Independent UK · Sep 10, 2025 Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications
The Guardian - UK · Sep 9, 2025 Junk food leads to more children being obese than underweight for first time Cheap ultra-processed food behind rise in overweight children, with one in 10 now obese globally, says Unicef
The Independent UK · Sep 9, 2025 Almost half of those with diabetes don’t know they have it. Are you one of them? Diabetes affects 38.4 million Americans, according to the Centers for Disease Control and Prevention
The Independent UK · Sep 8, 2025 UK ‘falling behind’ when it comes to diabetes diagnosis, study says Among western European countries, only Switzerland and France had lower diagnosis rates than the UK
The Independent UK · Sep 7, 2025 Weight-loss jabs are not enough to tackle the obesity crisis, experts warn THE UK’S OBESITY CHALLENGE : Weight-loss drug Mounjaro will be rolled out to a quarter of a million NHS patients. But leading experts tell Rebecca Thomas and Alicja Hagopian that weight-loss jabs alone will not be enough to solve the obesity crisis
The Independent UK · Sep 5, 2025 WHO has added GLP-1 drugs to the essential medicines list. Here’s what that means GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too
International Business Times · Sep 5, 2025 WHO Backs Weight-loss Drugs, Urges Cheap Generics The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
The Independent UK · Sep 5, 2025 Error means 55,000 patients require diabetes retests after potential misdiagnoses More than 55,000 patients may require new blood tests to receive an accurate blood glucose reading